- Treatment of associated anemia in different hematological disorders with epoetin alpha2004 | First Faculty of Medicine
- Efficacy and safety of luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): interim analysis of a phase 3, open-label, randomised controlled trial2023 | First Faculty of Medicine
- Epoetin alfa is a suitable treatment of anemia associated with different hematological disordersPublication without faculty affiliation
- Route of administration is only a small part of the answer how to optimally use epoetin alfaPublication without faculty affiliation
- Haemolytic anemia in patients treated with ribavirine - clinical experience and treatment2007 | Third Faculty of Medicine
- Binocrit - new biosimilar of epoietin2011 | First Faculty of Medicine
- Treatment of anaemia with erythropoiesis-stimulating proteins in patients with myelodysplastic syndrome2010 | First Faculty of Medicine
- Treatment of anaemia with erythropoiesis-stimulating proteins in patients with myelodysplastic syndrome2010 | Publication without faculty affiliation
- Anemia in patients with kidney disease and possibilities of management2011 | First Faculty of Medicine
- Phase I/II randomised study of a novel erythropoiesis-stimulating agent (AMG 114) for the treatment of anaemia with concomitant chemotherapy in patients with non-myeloid malignancies2011 | Publication without faculty affiliation
